Search | Sohomoy

Emma Verghise added blog Health
2026-06-29 18:24:55 -

Active Pharmaceutical Ingredient CDMO Market Outlook: Innovation Fueling Industry Expansion
The Active Pharmaceutical Ingredient CDMO Market continues to evolve as pharmaceutical companies increasingly embrace outsourcing strategies to improve operational efficiency, reduce manufacturing costs, and accelerate drug commercialization. According to Polaris Market Research, the market was valued at USD 108.14 billion in 2024 and is expected to grow from USD 116.11 billion in 2025 to USD...

0 Comments 0 Shares 72 Views

Please log in to like, share and comment!
Vikas Hundekar added blog Other
2026-07-04 17:56:51 -

Estradiol API Market Benefits from Innovation in Active Pharmaceutical Ingredient Manufacturing
According to WiseGuy Reports, the Estradiol API Market was valued at USD 3.73 Billion in 2025 and is projected to reach USD 6.0 Billion by 2035, registering a CAGR of 4.9% during the forecast period. Market growth is being driven by increasing demand for hormone replacement therapies, expanding treatment of hormone-related disorders, rising aging female population, advancements in...

0 Comments 0 Shares 39 Views

Please log in to like, share and comment!
Anjali Shinde added blog Health
2026-07-11 01:51:07 -

Innovation Driving Active Pharmaceutical Ingredient Excipient Market Expansion
The Active Pharmaceutical Ingredient (API) Excipient Market is experiencing a significant transformation, driven by the increasing complexity of drug formulations and the global push for improved bioavailability and therapeutic efficacy. As pharmaceutical companies strive to develop more sophisticated delivery systems, the demand for high-quality excipients—the inactive substances that...

0 Comments 0 Shares 9 Views

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-07-08 15:49:23 -

Small Molecule Innovator API CDMO Market Analysis by Development Stage and End User
The global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...

0 Comments 0 Shares 101 Views

Please log in to like, share and comment!